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Brief CommunicationsWe describe the case of a man with recurrent prosthetic mi-
tral valve dysfunction that was resolved indirectly with a mi-
tral valve homograft.
CLINICAL SUMMARY
A 54-year-old man with a diagnosis of mitroaortic endo-
carditis caused by methicillin-sensitive Staphylococcus epi-
dermidis underwent mitral and aortic valve replacement
(CarboMedics 31 mm and 23 mm; CarboMedics Inc, Austin,
Tex) and received cloxacillin benzathine (INN cloxacillin)
and gentamicin for 7 days, followed by cloxacillin for 5
weeks. Results of valve cultures and control blood cultures
at 15 and 60 postoperative days were negative. Six months
later, a first reoperation was performed because of endocar-
ditis of both prostheses. An aortic homograft substituting
the aortic root and a new CarboMedics prosthesis were
implanted. Results of valve cultures, blood cultures with
prolonged incubation, and serologic tests for Coxiella,
Brucella, Mycoplasma, and Bartonella infections were neg-
ative. Combined treatment with vancomycin, gentamicin,
and rifampin (INN rifampicin) for 2 weeks was adminis-
tered, followed by vancomycin and rifampin for 4 weeks.
Results of blood cultures were negative. Six months later,
a second reoperation was needed because of dehiscence of
the mitral prosthesis in the mitroaortic junction and macro-
scopic appearance of endocarditis. A new CarboMedics
prosthesis was inserted. Vancomycin and rifampin were em-
pirically administered during 6 weeks and gentamicin during
2 weeks. All cultures and serologic tests were unrevealing.
Three months later, a third prosthetic valve replacement
for infective endocarditis was performed. Results of cultures
and serologic tests were negative. The patient received line-
zolid and rifampin for 6 weeks because of poor tolerance of
vancomycin.
Six months later, the patient underwent a fourth reopera-
tion, this time for acute pulmonary edema and severe mitral
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Results of cultures and serologic tests were negative. Signs
of endocarditis at gross intraoperative inspection were not
observed. The prosthesis was not lined with endocardium
and showed dehiscence at various sites, particularly in the
mitroaortic junction. When the prosthetic ring was removed,
the native mitral ring had a raw flesh appearance, with sug-
gestive signs of rejection or intolerance to the Dacron poly-
ester fabric of the prosthetic suture ring. A complete mitral
homograft was implanted, with several 4-0 polypropylene
sutures used to fix the graft’s papillary muscles to the native
papillary projections. The graft annulus was fixed to the re-
cipient annulus with a running suture (3-0 polypropylene).
The annular suture was supported with a 28-mm CarboMed-
ics AnnuloFlex annuloplasty ring (4 mm smaller diameter
than the measured ring). A possible anterior paracommissur-
otomy leak was repair with the Alfieri procedure. After dis-
continuation of cardiopulmonary bypass, transesophageal
echocardiography showed severe residual mitral regurgita-
tion (grade 3/4). Under cardiopulmonary bypass, the pros-
thetic ring was removed, and a mechanical CarboMedics
29-mm prosthesis was implanted inside the mitral homograft
with a technique similar to transvalvular mitral prosthesis
implantation preserving the entire native valve apparatus.1
Methicillin-sensitive S epidermidis was isolated in the cul-
ture of the prosthetic valve. Results of blood cultures and se-
rologic tests were negative. Results of polymerase chain
reaction amplification followed by direct sequencing to
identify microbial pathogens in the tissue from mitral and
aortic valves were negative. Histopathologic examination
of a thrombus over the annulus of the mechanical prosthetic
valve revealed a predominantly eosinophilic infiltrate with-
out bacteria. Results of skin tests to suture threads and pros-
thetic ring material were negative. Combined treatment with
cloxacillin, rifampin, and gentamicin was given for 2 weeks,
followed by cloxacillin and rifampin for 5 weeks. Before the
patient’s discharge from the hospital, transesophageal echo-
cardiography showed residual mitral regurgitation (grade 2/
4). Currently, 14 months after implantation of a mechanical
prosthesis inside a supporting mitral valve homograft, the
patient is free of symptoms with mild regurgitation (grade
1/4; Figure 1).
DISCUSSION
The prognosis of patients with recurrent mitral valve
dysfunction undergoing one or more reoperations forgery c March 2009
Brief Communicationssubstitution of the prosthesis is very poor.2-4 In our case, four
consecutive reoperations were needed because of recurrent
prosthetic dehiscence and mitral valve dysfunction. It was
considered that a mitral homograft could be a valid alterna-
tive, but functional results were disappointing because of
limited mobility and deficient coaptation of the anterior
FIGURE 1. Transthoracic diastolic long-axis view. SA, Mitral homograft
subvalvular apparatus with papillary muscle and chordae tendineae; AH,
aortic homograft; L,mechanical mitral prosthesis leaflets; MH,mitral homo-
graft.Concomitant giant coronary artery a
Basar Sareyyupoglu, MD, James E. Davies, MD, Grace Lin, MD, and
Coronary artery aneurysms are uncommon, being noted in
0.15% to 4.9% of patients undergoing coronary angiogra-
phy. Only a small fraction of these aneurysms are of suffi-
cient size to be considered ‘‘giant,’’ a term commonly
applied when such lesions exceed 20 to 50 mm in diame-
ter.1,2 Coronary artery fistulae are equally rare, reportedly
occurring in 0.22% of patients undergoing cardiac catheter-
ization.3 Curiously, the former lesion has been reported
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the valve commissure were unsuccessful, and instead of
explanting the homograft it was decided to remove the annu-
loplasty ring and insert a bioprosthesis in a transvalvular
position, with the homograft acting as a native valve. At
14 months of follow-up, the patient is free of symptoms,
and functional results are satisfactory. Hypersensitivity to
the suture ring of the valve prosthesis is an appealing expla-
nation for our findings. In this respect, the interposed homo-
graft avoided the potential risk of intolerance to the suture
ring and also prevented direct contact between the infected
tissue and the prosthesis.
We thank Marta Pulido, MD, for editing the manuscript and for
editorial assistance.
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associated with the latter in 30%2 to 80%1 of cases, with
communication most often to the left ventricle,1 right ventri-
cle, or right atrium.2 One such fistula with associated dilata-
tion of the right coronary artery (RCA) but without frank
aneurysm has been reported to the coronary sinus (CS).4
We recently encountered a case of concomitant giant aneu-
rysms of the proximal RCA and CS, with a distal RCA–CS
fistula.
CLINICAL SUMMARY
An 82-year-old woman was admitted to the hospital with
worsening right heart failure. Three years previously, she
was incidentally discovered to have a giant RCA aneurysm.
Surgical repair was declined at that time by the patient.
Because of worsening symptoms of dyspnea on exertion
and pedal edema, however, the patient sought evaluation
at our institution. She denied angina pectoris.
ardiovascular Surgery c Volume 137, Number 3 763
